Evidence map›Paper›PMID 33113834›Full record

ArticleVaccines2020

Different Long-Term Duration of Seroprotection against

Milou Ohm, Debbie M van Rooijen, Axel A Bonačić Marinović, Mariëtte B van Ravenhorst, Marieke van der Heiden, Anne-Marie Buisman, Elisabeth A M Sanders, Guy A M Berbers

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Immunity Dynamics ofVaccines · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Milou OhmCentre for Infectious Disease Control (Cib), National Institute of Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
Debbie M van RooijenCentre for Infectious Disease Control (Cib), National Institute of Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
Axel A Bonačić MarinovićCentre for Infectious Disease Control (Cib), National Institute of Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
Mariëtte B van RavenhorstDepartment of Pediatrics, Amsterdam UMC, 1007 MB Amsterdam, The Netherlands.
Marieke van der HeidenDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 114 18 Stockholm, Sweden.ORCID 0000-0001-8525-9895
Anne-Marie BuismanCentre for Infectious Disease Control (Cib), National Institute of Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
Elisabeth A M SandersCentre for Infectious Disease Control (Cib), National Institute of Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
Guy A M BerbersCentre for Infectious Disease Control (Cib), National Institute of Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
National Institute for Public Health and the Environment · NLAmsterdam University Medical Centers · NLStockholm University · SE

Funding

Ministerie van Volksgezondheid, Welzijn en Sport no grant
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adolescentslong-term protectionmiddle-aged adultsNeisseria meningitidisquadrivalent meningococcal vaccineserum bactericidal antibody assay

Identifiers

PMID33113834
PMCPMC7712102
OpenAlexW3094630248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.